(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSIÇÕES FARMACÊUTICAS CONTENDO ANTICORPOS ANTI-LINGO-1

ArquivadaInvention PatentPCT · US2020021842

Application data

Number

112021017644

Type

Invention Patent

Filing

03/10/2020

Publication

11/16/2021

PCT

US2020021842

Progress at the INPI

  1. Filing03/10/20
  2. Publication11/16/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 03/10/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 09/05/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BIOGEN MA INC.

US

See this company's full portfolio

Inventors

J. F. (pessoa física)

US

S. S. (pessoa física)

US

Technical data

Priority claims

US

62/816,668 · 03/11/2019

US

62/817,323 · 03/12/2019

Abstract

COMPOSIÇÕES FARMACÊUTICAS CONTENDO ANTICORPOS ANTI-LINGO-1. A presente invenção refere-se a composições farmacêuticas contendo anticorpos anti-LINGO-1 ou fragmentos de ligação à LINGO-1 dos mesmos. Essas composições farmacêuticas são utilizadas no tratamento de doenças desmielinizantes do SNC, tais como esclerose múltipla e neurite óptica (por exemplo, neurite óptica aguda).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

09/05/2023

RPI 2748

Arquivamento - Art. 33 da LPI

#11.1

06/20/2023

RPI 2737

Notificação de entrada na fase nacional - PCT

#1.3

11/16/2021

RPI 2654

Alteração de dados cadastrais

#1.1

09/14/2021

RPI 2645

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.